Naus-ease
NDC Package 49467-104-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Naus-ease is for Consumers (the general public):Naus-Ease® (Meclizine Hydrochloride), USP Film Strips are used for the prevention and treatment of nausea and vomiting, or dizziness associated with motion sickness.For Health Professionals:Based on a review of Meclizine Hydrochloride, USP drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications of Meclizine Hydrochloride, USP as follows: 1. Marketed by Sunascen Therapeutics Llc, this product is identified by NDC 49467-104 and is authorized under FDA application part336.

Identification & Billing

NDC Package Code
49467-104-01
Package Description
8 POUCH in 1 CARTON / 1 FILM, SOLUBLE in 1 POUCH
Product Code
49467-104
11-Digit Billing Format
49467010401
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Naus-ease
Dosage Form
-
Usage Information
For Consumers (the general public):Naus-Ease® (Meclizine Hydrochloride), USP Film Strips are used for the prevention and treatment of nausea and vomiting, or dizziness associated with motion sickness.For Health Professionals:Based on a review of Meclizine Hydrochloride, USP drug by the National Academy of Sciences – National Research Council and/or other information, FDA has classified the indications of Meclizine Hydrochloride, USP as follows: 1. The prevention and treatment (management) of nausea and vomiting, and dizziness associated with motion sickness. 2. For the treatment of vertigo.

Regulatory & Marketing

Labeler Name
Sunascen Therapeutics Llc
FDA Application #
part336
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
04-16-2012
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (49467-104). Click a package code to view its specific billing and regulatory data.

49467-104-16
16 POUCH in 1 CARTON / 1 FILM, SOLUBLE in 1 POUCH

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 49467-104-01 identifies a specific commercial package of 8 pouch in 1 carton / 1 film, soluble in 1 pouch of Naus-ease, labeled by Sunascen Therapeutics Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Sunascen Therapeutics Llc on April 16, 2012. The current certification is valid through December 31, 2024.

How is this Sunascen Therapeutics Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 49467010401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
49467-104-01
11-Digit CMS (5-4-2)
49467-0104-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.